Related Experiment Video
Updated: Apr 12, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Preclinical mouse models of osteosarcoma
Özge Uluçkan1, Aude Segaliny2, Sander Botter3
1BBVA Foundation-CNIO Cancer Cell Biology Programme, Spanish National Cancer Research Centre (CNIO) , Madrid, Spain.
Osteosarcoma, a common childhood bone cancer, has poor survival rates, particularly with metastasis. This chapter details mouse models for studying osteosarcoma development and testing treatments.
Area of Science:
- Oncology
- Genetics
- Animal Models
Background:
- Osteosarcoma is the most common primary bone tumor, predominantly affecting children.
- Low survival rates are associated with osteosarcoma, especially when metastatic disease is present.
- Mouse models are crucial for understanding osteosarcoma tumorigenesis, metastasis, and evaluating therapeutic strategies.
Purpose of the Study:
- To review existing mouse models for osteosarcoma research.
- To provide methodologies for osteosarcoma research using mouse models.
Main Methods:
- Isolation of cell lines from genetically engineered mouse models (GEMMs).
- Gene modification techniques for osteosarcoma research.
- Tumor cell injection methods in mice.
- Imaging techniques for osteosarcoma assessment in vivo.
Main Results:
- This chapter provides a comprehensive overview of available osteosarcoma mouse models.
- Detailed protocols are presented for cell line isolation, genetic manipulation, tumor induction, and imaging.
Conclusions:
- Mouse models are indispensable tools for advancing osteosarcoma research.
- The methodologies described facilitate the study of osteosarcoma mechanisms and the development of novel therapies.
More Related Videos
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021